Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

The proportion of non-transplant-eligible (NTE) newly diagnosed multiple myeloma (NDMM) patients excluded from clinical trials (CTs) and their prognosis is unknown. CT results may not be generalizable to real-world practice due to strict recruitment criteria. We analyzed causes of NTE-NDMM patient e...

Full description

Bibliographic Details
Main Authors: Luis Gerardo Rodríguez-Lobato, Natalia Tovar, Anna de Daniel, Carlos Fernández de Larrea, M. Teresa Cibeira, Raquel Jiménez-Segura, David F. Moreno, Aina Oliver-Caldés, Joan Bladé, Laura Rosiñol
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
multiple myeloma
clinical trial
real world
survival
trial effect
trial enrollment
Online Access:https://www.mdpi.com/2072-6694/15/21/5261

Internet

https://www.mdpi.com/2072-6694/15/21/5261

Similar Items